Rituximab as third-line treatment for refractory or recurrent Stage III or IV follicular non-Hodgkin's lymphoma
Subtitle: a systematic review and economic evaluation
By: B. Wake ... [et al.].
Contributors: Wake, B.; National Co-ordinating Centre for HTA (Great Britain); Health Technology Assessment Programme.
Series: Health technology assessment -- v.6, no.3
Publisher: Core Research on behalf of the NCCHTA
Published: 2002
Place of publication: Alton
Language: eng
Number of pages: 85
Other titles: Rituximab for non-Hodgkin's lymphoma.
Notes: Spine title: Rituximab for non-Hodgkin's lymphoma.

Includes bibliographical references.